Tag: Jason Vegotsky
An FDA Primer: 6 Key Questions That Need Answers at The CBD Hearing
On May 31, the Food and Drug Administration (FDA) will finally convene to debate the safety and efficacy of cannabidiol (CBD), a non-active compound...
